Norepinephrine transporter-derived homing peptides enable rapid endocytosis of drug delivery nanovehicles into neuroblastoma cells

BACKGROUND: Currently, the diagnosis and treatment of neuroblastomas—the most frequent solid tumors in children—exploit the norepinephrine transporter (hNET) via radiolabeled norepinephrine analogs. We aim to develop a nanomedicine-based strategy towards precision therapy by targeting hNET cell-surf...

Descripción completa

Detalles Bibliográficos
Autores principales: Haddad, Yazan, Charousova, Marketa, Zivotska, Hana, Splichal, Zbynek, Merlos Rodrigo, Miguel Angel, Michalkova, Hana, Krizkova, Sona, Tesarova, Barbora, Richtera, Lukas, Vitek, Petr, Stokowa-Soltys, Kamila, Hynek, David, Milosavljevic, Vedran, Rex, Simona, Heger, Zbynek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359476/
https://www.ncbi.nlm.nih.gov/pubmed/32660596
http://dx.doi.org/10.1186/s12951-020-00654-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359476/
https://www.ncbi.nlm.nih.gov/pubmed/32660596
http://dx.doi.org/10.1186/s12951-020-00654-x

Ejemplares similares